Icahn raised his stake to 23.1%, according to an SEC filing. He had previously held a 20.8% stake in the nutritional supplements company.
Separately, TheStreet Ratings team rates the stock as a "hold" with a ratings score of C.
Herbalife's strengths such as its notable return on equity, revenue growth and good cash flow from operations are countered by weaknesses including deteriorating net income and generally higher debt management risk.
You can view the full analysis from the report here: HLF
TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this article's author.